Synthetic Process for Cleistanthin A Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating Cleistanthin A from Cleistanthus collinus are complex and inefficient, lacking a synthetic process for this valuable compound with potential antitumor and anti-inflammatory properties.
Innovation Solution
A synthetic process involving the reaction of compound II with compound III in the presence of a quarternary ammonium salt and alkali in dichloromethane, followed by treatment with potassium carbonate in methanol, to produce Cleistanthin A with a high yield of 96%, facilitating the production of Cleistanthin A acetate.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional isolation methods are used to obtain Cleistanthin A from Cleistanthus collinus, then the compound can be obtained, but the process is complex and inefficient with low yield
Solution Approach 1:
The patent changes the fundamental approach from natural product isolation to chemical synthesis. By transforming the production methodology from extraction-based to synthesis-based, the process achieves 96% yield compared to the low yield of conventional isolation methods, while simplifying the overall production pathway
Solution Approach 2:
The synthesis process is divided into distinct sequential steps: Step 1 reacts compound II with compound III in dichloromethane with tetrabutylammonium bromide and sodium hydroxide to form intermediate IV; Step 2 treats intermediate IV with potassium carbonate in methanol to produce final product I. This segmentation enables precise control and optimization of each step, achieving high overall efficiency
2Ease of manufacture
If conventional isolation methods are used, then Cleistanthin A can be obtained, but the process is not economically viable
Solution Approach 1:
The patent transforms the production economics by changing from low-yield isolation to high-yield synthesis (96%). This parameter change in production methodology directly improves economic viability by reducing material waste, lowering production costs, and increasing output efficiency
Solution Approach 2:
The patent introduces intermediate compound IV (Cleistanthin A acetate) as a mediator in the synthesis pathway. This intermediate allows for controlled stepwise transformation from starting materials to final product, enabling efficient production with 96% yield and improved economic feasibility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process simplifies the production of Cleistanthin A, achieving a high yield and providing a more economically viable method for obtaining this compound, which can be used in treating diseases such as cancer and excessive gastric acidification.
Implementation Method 1
reacting compound of formula II with compound of formula III in the presence of a first solvent, a quarternary ammonium salt and a first alkali to form compound of formula IV
Implementation Method 2
reacting compound of formula II with compound of formula III in the presence of a first solvent, a quarternary ammonium salt and a first alkali to form compound of formula IV
Implementation Method 3
The compound of formula IV is further treated with a second solvent and a second alkali to form compound of formula I
Data Source
AI summary
The present invention relates to a process for preparing compound of formula (I) that is Cleistanthin A. The process comprises the steps of reacting compound of formula (II) with compound of formula (III) in the presence of a first solvent, quarternary ammonium salt and first alkali to form compound of formula (IV). The compound of formula (IV) is further treated with a second solvent and a second alkali to form compound of formula (I). The present invention also relates to the preparation of salt of compound of formula (IV) that is Cleistanthin A acetate.